Foot-and-mouth disease virus antigenic landscape and reduced immunogenicity elucidated in atomic detail

Haozhou Li1, Pan Liu2,3, Hu Dong1

  • 1State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.

Nature Communications
|October 10, 2024
PubMed

Insights

Foot-and-mouth disease virus (FMDV) intact virions (146S) dissociate into subunits (12S), altering epitopes and reducing immunogenicity. Understanding these structural changes guides the design of effective FMDV vaccines.

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • Foot-and-mouth disease virus (FMDV) intact 146S virions readily dissociate into 12S subunits, a process linked to decreased immunogenicity.
  • The precise mechanism by which FMDV dissociation impacts immunogenicity remains poorly understood.

Purpose of the Study:

  • To elucidate the structural basis for the differential immunogenicity of FMDV 146S and 12S particles.
  • To characterize the antigenic landscape of FMDV 146S and identify antibody binding sites.

Main Methods:

  • High-resolution cryo-electron microscopy (cryo-EM) to determine structures of 12S, 146S, and their complexes with single-domain antibodies (VHHs).
  • Analysis of 13 FMDV-antibody complexes to map the antigenic landscape.
  • Comparative immunogenicity studies in pigs to assess antibody responses to 12S and 146S particles.

Main Results:

  • Determined high-resolution structures of FMDV 12S and 146S particles complexed with VHH antibodies.
  • Structural analysis revealed that FMDV 146S dissociation leads to epitope alteration and destruction.
  • 146S particles induced higher synergistic neutralizing antibody titers compared to 12S particles, despite similar total antibody titers.

Conclusions:

  • FMDV 146S dissociation significantly alters the antigenic surface, impacting antibody recognition and immune response.
  • Structural insights into FMDV antigenicity can inform the rational design of improved recombinant vaccines.
  • This work provides a foundation for developing multivalent and broad-spectrum FMDV vaccines.